FIELD: medicine, oncology.
SUBSTANCE: invention relates to method for malignant tumor treatment (including cancer, sarcoma, melanocytoma) in human by ectasceine ET743 intravenous infusion in dose of 500-1650 mug/m2 of surface are; to similar treatment by combination of ET743 with antiemetic agent; as well as to relative composite preparation. Method of present invention provides clinical amelioration in subject suffering from progressive or metastasing cancer and improves treatment effectiveness of diseases being progressed after known chemotherapy.
EFFECT: new effective method for cancer treatment; drug with good acceptability.
31 cl, 3 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINED APPLICATION OF ECTEINASCIDIN-743 AND PLATINUM-CONTAINING ANTI-TUMOUR COMPOUNDS | 2004 |
|
RU2391101C2 |
| IMPROVED SCHEME OF USING ANTITUMOR COMPOUND IN CANCER THERAPY | 2002 |
|
RU2306933C2 |
| PEGYLATED LIPOSOMAL DOXORUBICINUM IN COMBINATION WITH ECTEINESCIDIN 743 | 2005 |
|
RU2359700C2 |
| TREATMENT OF MALIGNANT TUMOR WITH APLIDINE | 2000 |
|
RU2261104C2 |
| APPLICATION OF SINGLE DOSE OF CD20-SPECIFIC BINDING MOLECULES | 2006 |
|
RU2421242C2 |
| METHODS FOR TREATING PANCREATIC CANCER USING COMBINATION THERAPY COMPRISING LIPOSOMAL IRINOTECAN | 2013 |
|
RU2663450C2 |
| METHODS OF TREATING PANCREAS CANCER USING COMBINATION THERAPY INCLUDING LIPOSOMAL IRINOTECAN | 2013 |
|
RU2808427C2 |
| KAHALALIDE F | 2001 |
|
RU2292216C2 |
| ANTIBODIES AGAINST PD-1 FOR TREATMENT OF LUNG CANCER | 2018 |
|
RU2771759C2 |
| METHODS OF APPLYING (+)-1,4-DIHYDRO-7-[(3S,4S)-3-METHOXY-4-(METHYLAMINO)-1-PYRROLIDINYL]-4-OXO-1-(2-THUASOLYL)-1,8-NAPHTHYDIRINE-3-CARBOXYLIC ACID FOR TREATMENT OF CANCER | 2006 |
|
RU2428983C2 |
